Type 2 diabetes mellitus: Added benefit of canagliflozin is not proven

(Institute for Quality and Efficiency in Health Care) In its dossier, the drug manufacturer presented no suitable data for canagliflozin -- neither as monotherapy nor in combination with metformin, sulfonylurea or insulin.

Source: EurekAlert! - Medicine and Health - June 17, 2014 Category: Global & Universal Source Type: news